Neoadjuvant carboplatin/paclitaxel (CP) followed by concurrent CP and dose escalating thoracic conformal radiation therapy (TCRT) in stage III non-small cell lung cancer (NSCLC): a phase I/II trial
1998 ◽
Vol 42
(1)
◽
pp. 334
◽
Keyword(s):
Phase I
◽
2014 ◽
Vol 90
(1)
◽
pp. S580
◽